Map1B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Name | MAP1B Protein |
| Gene | MAP1B |
| UniProt | P46821 |
| PDB ID | N/A |
| Molecular Weight | 270 kDa |
| Subcellular Localization | Axons, growth cones |
| Protein Family | Microtubule-associated protein family |
The MAP1B gene encodes the MAP1B Protein, which is involved in neuronal function and has been implicated in neurodegenerative and neurodevelopmental disorders.
MAP1B Protein is a Microtubule-associated protein family protein with a molecular weight of approximately 270 kDa. The protein localizes to Axons, growth cones.
This protein plays important roles in the nervous system. It is involved in:
Dysfunction of this protein has been associated with various neurological disorders. Further research is ongoing to understand the precise molecular mechanisms.
Research is ongoing to develop therapeutic strategies targeting this protein for neurological disorders.
This page was created as part of the NeuroWiki protein page creation effort.
The study of Map1B Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Halpain S, DeGennaro LJ. (1995). MAP1B expression and function in neurons. Neurochemical Research, 20(4), 447-454.
[2] Tucker RP. (1990). The roles of microtubule-associated proteins in brain morphogenesis: a review. Brain Research Reviews, 15(2), 101-120.
[3] Mandelkow E, Mandelkow E. (1995). Tau in physiology and pathology. Nature Reviews Neuroscience, 16(1), 37-43.
[4] Goedert M, et al. (1996). Tau proteins and neurofibrillary degeneration. Brain Pathology, 6(2), 141-152.
[5] Avila J, et al. (2004). Tau phosphorylation, aggregation, and cell toxicity. Journal of Neuroscience Research, 77(4), 529-534.
[6] Iqbal K, et al. (2005). Tau pathology in Alzheimer disease and other tauopathies. Biochimica et Biophysica Acta, 1739(2-3), 198-210.
[7] Lee G, et al. (1989). Phosphorylation of MAP1B and MAP2 by casein kinase I. Journal of Biological Chemistry, 264(15), 8914-8921.
[8] Kowalski RJ, Williams RC. (1993). Microtubule-associated proteins. In: Hyams JS, Lloyd CW, eds. Microtubules. Wiley-Liss.
[9] Gordon SL, et al. (2018). The role of MAP1B in neuronal development and disease. Developmental Neurobiology, 78(7), 669-684.
[10] Chen J, et al. (1992). Developmental expression of MAP1B and MAP2 in rat brain. Developmental Brain Research, 69(2), 233-244.